Results 41 to 50 of about 101,215 (169)

Get your JAB now!

open access: yes, 2023
Get your JAB now!
Pruritus Migrans
core   +1 more source

Causes of Pruritus in Patients Treated With Immune Checkpoint Inhibitors for Melanomas or Skin Carcinomas

open access: yesFrontiers in Medicine, 2021
Background: Pruritus is a frequent adverse event during the use of immune checkpoint inhibitors (ICIs), with a frequency estimated to be between 11 and 47%.
Nadia Salinas   +12 more
doaj   +1 more source

Nalfurafine hydrochloride to treat pruritus: a review [PDF]

open access: yes, 2015
Shigeki InuiDepartment of Regenerative Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanAbstract: Uremic pruritus has a great negative influence on quality of life in hemodialysis (HD) patients and, importantly, negatively affects ...
Inui S
core  

WARNING!

open access: yes, 2021
WARNING!
Pruritus Migrans
core   +1 more source

Validation of Relationship between Patients’ Descriptions of Pruritus and Patient-burden of Chronic Pruritus using Structural Equation Modelling

open access: yesActa Dermato-Venereologica, 2022
Patients with chronic itch describe their pruritus in a wide variety of ways. However, these subjective descriptions are often not taken into consideration by physicians. This study aimed to validate patients’ descriptions of pruritus, and to investigate
Ji Hoon Ryoo   +16 more
doaj   +1 more source

Effectiveness of Aprepitant in Patients with Refractory Pruritus Secondary to Sézary Syndrome [PDF]

open access: yes, 2012
Background: In advanced stages, patients with Sézary Syndrome (SS) commonly report an ill-defined, severe and diffuse pruritus. Recently, it has been reported that Aprepitant, an oral neurokinin-1-receptor (NK1) antagonist, may have an important role in ...
Fernandes, I.   +4 more
core   +1 more source

DARE

open access: yes, 2021
DARE * PRURITUS MIGRANS * CC: BY-NC ...
Pruritus Migrans
core   +1 more source

Comparative Analysis of Patient-Reported Outcomes in Chronic Pruritus: Patients with Chronic Liver or Kidney Diseases Exhibit Higher Psychological Distress than Those with Atopic Dermatitis

open access: yesDermatology and Therapy
Introduction Chronic pruritus (CP; lasting ≥ 6 weeks) is a prevalent symptom with diverse underlying conditions, including chronic liver diseases (CLD), chronic kidney diseases (CKD) and atopic dermatitis (AD).
Svenja Royeck   +15 more
doaj   +1 more source

Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis

open access: yesActa Dermato-Venereologica, 2020
Prurigo nodularis is an itchy skin disease with unknown epidemiology. This study aimed to describe the epidemiology of prurigo nodularis compared with that of psoriasis.
Sonja Ständer   +6 more
doaj   +1 more source

Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction

open access: yesActa Dermato-Venereologica, 2021
Chronic nodular prurigo is characterized by recalcitrant itch. Patient perspectives on therapeutic goals, satisfaction with therapy and efficacy of therapeutic regimens for this condition are unknown. This questionnaire study examined these issues in 406
Manuel P. Pereira   +27 more
doaj   +1 more source

Home - About - Disclaimer - Privacy